Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference
May 30, 2024 07:30 ET
|
Mereo BioPharma Group plc
LONDON, May 30, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced...
PodcastOne (Nasdaq: PODC) Reports Record Fiscal Year 2024 Results
May 30, 2024 07:30 ET
|
PodcastOne
Record Revenue of $43.3M for FY 2024, $11.7M for Q4 FY 2024Adjusted EBITDA* of $0.7M for FY 2024, $258K for Q4 FY 2024 Financial Highlights: Increased Shareholders’ Equity by $9M from Prior Fiscal...
Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea
May 30, 2024 07:30 ET
|
Incannex Healthcare
NEW YORK and MELBOURNE, Australia, May 30, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique medicinal...
Dyne Therapeutics to Present at Jefferies Global Healthcare Conference
May 30, 2024 07:30 ET
|
Dyne Therapeutics, Inc.
WALTHAM, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for...
Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
May 30, 2024 07:30 ET
|
Pyxis Oncology
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers,...
Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference
May 30, 2024 07:30 ET
|
Sensei Biotherapeutics
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation...
Vigil Neuroscience to Present in Upcoming June Investor Conferences
May 30, 2024 07:05 ET
|
Vigil Neuroscience, Inc.
WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of...
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
May 30, 2024 07:00 ET
|
Omega Therapeutics
CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable...
LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference
May 30, 2024 07:00 ET
|
LAVA Therapeutics N.V.
UTRECHT, The Netherlands and PHILADELPHIA, May 30, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA,” or “Company”), a clinical-stage immuno-oncology company focused on...
Virtu Financial, Inc. Announces Investor Meetings for Potential Opportunistic Offering of Senior Secured First Lien Notes
May 30, 2024 07:00 ET
|
Virtu Financial, LLC
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Virtu Financial Inc. (Nasdaq: VIRT) (the “Company”) announced today that it intends to hold one or more meetings with potential investors with respect to a...